|
Restylane
News
Restylane
Lasts up to 18 Months
Medicis Announces FDA Approval of PMA Supplement for RESTYLANE:
Study Demonstrates RESTYLANE Effect Persisted Up to 18 Months
in Duration in 97 Percent of Patients With One Repeat Injection
Medicis
Begins Shipping PERLANE to Physicians
Newest Member of the Worldwide Market Leading RESTYLANE Family
of Hyaluronic Acid Dermal Filler Products is Now Available
to U.S. Physicians
Medicis
Announces First Shipment of RESTYLANE to Physicians
RESTYLANE(R) is the first and only dermal filler made of crystal-clear
gel called NASHA(TM) (Non-Animal Stabilized Hyaluronic Acid).
NASHA(TM) is developed using a unique stabilization process
that results in its long duration of effect in contrast to
non-stabilized hyaluronic acid, which lasts only days to weeks,
at most
The
FDA's advisory panel recommends approval of RESTYLANE
Medicis (NYSE: MRX) today announced that a Food and Drug Administration
("FDA") Advisory Panel has recommended the approval
of RESTYLANE(R), a dermal filler, by a vote of 6 to 3.
RESTYLANE
more effective than Zyplast
Restylane is significantly more effective than Zyplast for
the correction of nasolabial folds, results from a randomized,
evaluator-blind, multicenter trial suggest. Furthermore, the
longevity of Restylane is superior to that of Zyplast.
|
